| 规格 | 50ug |
|---|---|
| 表达宿主 | Human Cells |
| 标签 | NA |
| 分子量 | 23 KDa |
|---|---|
| 表观分子量 | 25-33 KDa, reducing conditions |
| 形态 | Lyophilized from a 0.2 μm filtered solution of 20mM PB, 500mM NaCl, 2mM EDTA, pH 7.4. |
| 纯度 | Greater than 95% as determined by reducing SDS-PAGE. |
| 内毒素水平 | Less than 0.01 EU/µg as determined by LAL test. |
|---|---|
| 活性 | Measured by its ability to inhibit BMP-2-induced alkaline phosphatase production by ATDC5 mouse chondrogenic cells The ED50 for this effect is 0.2 μg/mL in the presence of 2000 ng/mL of Recombinant Human BMP‑2(#C012) |
| 溶解方法 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
|---|---|
| 储存方法 | Lyophilized protein should be stored at < -20°C, though stable at room temperature for 3 weeks. Reconstituted protein solution can be stored at 4-7°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months. |
| 运输条件 | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature listed below. |
| 背景说明 | Noggin is a secreted homodimeric glycoprotein that is an antagonist of bone morphogenetic proteins (BMPs). Mature Human Noggin contains an N-terminal acidic region, a central basic heparin-binding segment and a C-terminal cysteine-knot structure. Noggin is very highly conserved among vertebrates, such that mature human Noggin shares 99%, 99%, 98%, 97% and 89% aa sequence identity with mouse, rat bovine, equine and chicken Noggin, respectively. Secreted Noggin probably remains close to the cell surface due to its binding of heparin-containing proteoglycans. Noggin binds some BMPs such as BMP4 with high affinity and others such as BMP7 with lower affinity. It antagonizes BMP bioactivities by blocking epitopes on BMPs that are needed for binding to both type I and type II receptors. Noggin is expressed in defined areas of the adult central nervous system and peripheral tissues such as lung, skeletal muscle and skin. During culture of human embryonic stem cells (hESC) or neural stem cells under certain conditions, addition of Noggin to antagonize BMP activity may allow stem cells to proliferate while maintaining their undifferentiated state, or alternatively, to differentiate into dopaminergic neurons. |
|---|
| 产品名称 | 点击数 |
|---|---|
| 地克珠利-BSA(或OVA)抗原 | 3797 |
| 牛血清白蛋白(BSA) | 3970 |
| 赛庚啶-BSA(或OVA)抗原 | 3856 |
| 丙酸睾酮-BSA(或OVA)抗原 | 3948 |
| 三聚氰胺(MEL)-BSA(或OVA)抗原 | 3730 |
| 苯甲酸雌二醇-BSA(或OVA)抗原 | 3837 |
| 红霉素-BSA(或OVA)抗原 | 3849 |
| 喹乙醇代谢物MQCA-BSA(或OVA)抗原 | 3795 |
| 双酚A-BSA(或OVA)抗原 | 3700 |
| 大观霉素-BSA(或OVA)抗原 | 3750 |
| 磺胺对甲氧嘧啶(SMD)-BSA(或OVA)抗原 | 3759 |
| 磺胺间甲氧嘧啶-BSA(或OVA)抗原 | 3881 |
| 磺胺噻唑-BSA(或OVA)抗原 | 3901 |
| 磺胺甲基嘧啶-BSA(或OVA)抗原 | 3679 |
| 磺胺异恶唑-BSA(或OVA)抗原 | 3696 |
| 磺胺嘧啶(SD)-BSA(或OVA)抗原 | 3869 |
| 磺胺喹恶啉-BSA(或OVA)抗原 | 3737 |
| 磺胺二甲嘧啶(SM2)-BSA(或OVA)抗原 | 3780 |
| 磺胺甲恶唑-BSA(或OVA)抗原 | 3930 |
| 磺胺类(Sas)-BSA(或OVA)抗原 | 3865 |